We are an experienced team of VISIONARIES, STRATEGISTS, and INNOVATORS dedicated to improving patient outcomes. We've recently raised our series A round of funding and are looking forward to changing the lives of many.
Octave Bioscience an early stage molecular diagnostics company focused on neurodegenerative diseases and conditions.
MS disease course is driven by inflammation, demyelination and axonal damage. Yet, the tools to assess these are subjective, qualitative and inadequate.
Our team is developing novel measurement tools that feed into structured analytical data models to improve patient management decisions, create better outcomes and lower costs. We are focused on neurodegenerative diseases starting with multiple sclerosis (MS).